In an announcement of the ANDA approval record, Acting US FDA Commissioner Norman Sharpless said the generic program "continues to impress me." • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
